Dr. John William Horlebein, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 532 E. Woodin Avenue, Chelan, WA 98816 Phone: 509-679-1415 Fax: 509-679-1415 |
Northern Cascades Foot And Ankle, Llc Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 532 E. Woodin Ave, Chelan, WA 98816 Phone: 509-679-1415 |
Chelan-okanogan Foot & Ankle Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 503 E Highland Ave, Chelan, WA 98816 Phone: 509-682-3300 Fax: 509-682-6131 |
News Archive
Emergency Management & Safety Solutions (EMS), the crisis planner for many Fortune 100 companies, international government agencies and large non-profit organizations, is providing free resources to help people prepare for, prevent transmission of and take care of the ill to survive this wave of this year's H1N1 flu pandemic. Today, over 180 countries have experienced the H1N1 virus outbreak and at least 3,486 people have died – including 1,000 Americans.
"Activists are reigniting their attacks against President Obama's record on battling AIDS ahead of the International AIDS Conference in Washington later this month," The Hill's "Global Affairs" blog reports.
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute identifies a substance released by pancreatic cancer cells that protect them from attack by immune cells called macrophages.
Every year, more than 250,000 women in the U.S. are diagnosed with breast cancer. When detected early, patients with the most common form-which tests positive for hormone receptors (HR+) and negative for the HER2 receptor-usually respond well to treatment.
Clinicians from the McGill University Health Centre and the Centre hospitalier de l'Université de Montréal (CHUM) are participating in the first Canadian therapeutic HIV vaccine trial. Funded by a number of public and private institutions, including the Canadian Network for Vaccines and Immunotherapeutics (CANVAC) and the Canadian Institutes of Health Research, this project will begin in April.
› Verified 4 days ago